Sage Therapeutics said in a release that 64 percent of patients achieved Major Depression Disorder remission using the SAGE-217 drug in the 15th day of treatment. Read the article here.
Sage Therapeutics said in a release that 64 percent of patients achieved Major Depression Disorder remission using the SAGE-217 drug in the 15th day of treatment. Read the article here.
Built by Staple Creative